◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Noile-Immune Biotech Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 13, 2024Q4 2023Dec 31, 2023
+Operating Income -681.8M -- -481.5M --
Operating Margin % 99.9% -- 57.8% --
+Ordinary Income -682.2M -- -832.3M --
Revenue Growth % -- -- -- --
Line ItemQ3 2025Aug 08, 2025Q4 2024Dec 31, 2024Q3 2024Aug 13, 2024Q4 2023Dec 31, 2023
Current Assets 4.8B -- 5.7B --
Total Assets 4.8B 5.5B 5.8B 6.2B
Current Liabilities 69.4M -- 86.3M --
Total Liabilities 74.7M 107.2M 91.5M 201.8M
Total Equity 4.7B 5.3B 5.7B 6.0B
Equity Ratio -- 0.98 -- 0.97
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...